Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SER100 in Isolated Systolic Hypertension
NCT01987284Phase 2Completed
- Sponsor
- Serodus
- Start
- Oct 2013
- Primary completion
- Jul 2014
- Modality
- Peptides, Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of SER-100 in isolated systolic hypertension (ISH), sponsored by Serodus. Started Oct 2013; status: completed.
02
Drugs
SER-100
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on NCT01987284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987284.